The neutralizing antibody response to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for virus control and survivalOral abstract session with live Q&ABasic science
Neighborhood-level versus city-wide SARS-CoV-2 restrictions: can transmission be reduced while minimizing the potential for economic harms?Oral abstract session with live Q&ANon-pharmaceutical prevention
Early rollout of COVID-19 vaccines providing protection against infection rather than symptoms would prevent the most cases and deaths in King County, Washington, US: a modeling analysisOral abstract session with live Q&AVaccines
Expanded multi-month dispensing (MMD) policies for antiretroviral therapy (ART) ensure treatment continuity while mitigating potential exposure to COVID-19 in health facilitiesOral abstract session with live Q&AGlobal access and policy
Identification of SARS-CoV-2 T-cell epitopes for assessing T-cell immunityOral abstract session with live Q&ABasic science
Comparison of COVID-19 vaccine prioritization strategies for CaliforniaOral abstract session with live Q&AVaccines
Could mass testing reduce the need for social distancing and other restrictions during the SARS-CoV-2 pandemic? A mathematical modeling analysisOral abstract session with live Q&ANon-pharmaceutical prevention
Characterizing SARS-CoV-2 spread on college campusesOral abstract session with live Q&ANon-pharmaceutical prevention
seek-warrow-warrow-eseek-e81 - 88 of 88 items